Hello! I'm your financial analysis assistant. This news article discusses a very specific, yet often overlooked aspect of the robotics industry—the “joints.”
To help you understand this easily, I'll first summarize the main points of the news in plain language and then break down the logic behind it from five different perspectives.
📝 Summary of the Key Points
In simple terms, companies that manufacture the “skeleton” and “muscles” (i.e., the joints) of robots are more sought after by investors than those that build complete robots. They receive faster and larger amounts of funding as well. Nanjing Inx, a company specializing in robot joints, just received over 300 million yuan in funding. A week before that, its competitor, Quanzhibo, also received several hundred million yuan. This indicates that investors are more interested in the core components that are essential for robots, as opposed to the robots themselves, which are still in the development stage. Inx claims to have sold 100,000 joints this year, and many robots used in competitions rely on their products. However, it's unclear how many of these sales were actual profitable commercial orders and how many were just demonstration units for competitions. As more companies expand production, there is a potential for “overcapacity” and “price wars,” which presents both opportunities and significant risks for these firms.
---
🔍 In-Depth Analysis: Understanding the “Joint Business” from Five Perspectives
1. Why Do Investors Suddenly Favor Joint Manufacturers? – They Buy Certainty
You might think that investing in companies that make fully functional robots, like those that can dance or cook, would be a good idea, as it seems more exciting. But from an investor's perspective, investing in a robot manufacturer is like betting on which form of robot will become popular. Today, bipedal humanoid robots are in fashion; tomorrow, it could be wheeled robots, and who knows, robots might not even need to look human at all. If the bet is wrong, the investment could be lost.
Joints, on the other hand, are essential regardless of the robot's design. Whether it has two legs, four legs, or wheels, it needs joints consisting of motors, reducers, and sensors to move. Just like you need tires and an engine whether you drive a Mercedes or a BYD, robots need joints to function.
Therefore, investors are buying into joint manufacturers as they are essentially buying an option for the future growth of the robotics market. They are betting on the overall increase in the number of robots, which means joints will always be in demand, making this a more stable investment compared to focusing on a single product.
2. Are 100,000 Units Really a Significant Number? – Don’t Be Misled by the Figures
The news mentions that Inx aims to sell 100,000 joints by 2025, which sounds impressive. However, we need to be cautious. A single robot usually has several joints, so 100,000 joints might correspond to only a few hundred or even fewer complete robots. These 100,000 units represent the number of parts, not the number of complete robots.
Moreover, it’s unclear how many of these sales are profitable commercial transactions and how many are demonstration units for competitions. Many of the robots used in competitions are research prototypes or custom-made for the event, and these orders may not generate significant profits. Inx has not disclosed its revenue, profit margin, or repurchase rate, so these 100,000 units mainly show that it can produce and deliver the parts, not that it can make a substantial profit from them.
3. Is Self-Development and Production a Advantage or a Burden? – A Double-Edged Sword
Inx specializes in self-development and production, meaning it manufactures its own motors, drivers, and reducers instead of buying them from others. This has several benefits:
- Cost control: No need to pay middlemen.
- Quality assurance: Better control over quality due to in-house manufacturing.
- Standardization: It’s easier to produce standardized components that can be used by multiple customers.
However, there are also significant drawbacks:
- High initial investment: Building factories, purchasing equipment, and hiring research staff requires a large amount of capital.
- Risk concentration: If market demand slows down, these expensive production lines can become a major burden, leading to high costs, equipment depreciation, and inventory buildup.
This is similar to running a high-end restaurant where you grow your own vegetables, grind your own flour, and bake your own bread. If you have many customers, your profits can be high, but if business dries up, the expensive equipment and ingredients can lead to losses. In contrast, companies that only focus on assembly and purchase parts may have lower profits, but they are more flexible and more resilient to market changes.
4. The Coming Challenge of Overcapacity and Price Wars
There are clear signs that companies are rapidly expanding production. Quanzhibo plans to build production capacity for millions of units, and Inx is also investing in manufacturing. Many traditional manufacturers of reducers and motors are entering the market as well. This leads to a problem: Everyone is building factories based on the assumption that the robotics market will explode in the future, but the actual orders may not keep up with this pace.
This is similar to the photovoltaic industry in 2015 or the new energy vehicle battery industry in 2018, where capacity grew much faster than sales. When capacity exceeds demand, price wars often occur among suppliers (in this case, joint manufacturers). If price wars break out, companies with better cost control and stronger cash flows will survive. Inx is already spending a significant portion of its funding on capacity expansion. If the robotics market doesn’t grow as expected in the next two to three years, these new production lines could become a financial burden.
5. Expanding from Just Selling Joints to a Complete Range of Products: The Appeal and Risks of Diversification
Inx has expanded its offerings to include flexible hands, communication modules, and battery systems. This seems like a good strategy, as it provides customers with a one-stop solution and increases customer loyalty and value per purchase. However, it’s also a double-edged sword:
- Synergies: If these products work well together, they can create a competitive advantage.
- Increased management complexity: Managing multiple product lines requires different skills and resources.
- Resource allocation: Diversifying resources may dilute the company’s focus and reduce its efficiency.
The news emphasizes that Inx needs to demonstrate that these new products complement each other effectively, rather than just expanding for the sake of appearing more comprehensive. Otherwise, it could lead to increased operational risks and costs.
💡 Lessons for Everyone
1. When analyzing an industry, focus on the companies that supply essential components. They tend to be more stable but also face greater competition.
2. Be wary of overcapacity, as it often precedes a brutal price war.
3. Be skeptical of numbers like 100,000 units in sales. Ask whether they represent sales to end-users or to research institutions, and whether they are profitable or strategic in nature.
In summary, the funding for Inx and Quanzhibo marks a shift in the robotics industry from a phase of hype to one of intense competition based on manufacturing, cost control, and production capacity. The key will be which companies can survive the price wars and wait for the day when robots become a common part of everyday life.